Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TNX-102 SL (Tonmya) in Fibromyalgia (RELIEF)
NCT04172831Phase 3Completed
- Sponsor
- Tonix Pharmaceuticals
- Start
- Dec 2019
- Primary completion
- Oct 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of Tonmya in fibromyalgia (FM), sponsored by Tonix Pharmaceuticals. Started Dec 2019; status: completed.
02
Drugs
Tonmya
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT04172831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04172831.